Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study

The purpose of this study is to identify risk factors for thromboembolic and /or infectious complications in 3,000 patients with solid tumor and receiving a Percutaneous Central Venous Catheter (PCVC). A better understanding of the risk factors for these complications in this population would then allow interventional studies to be proposed to assess the benefit of prophylactic procedures in a sub-group of patients at most risk.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CH d'Annecy, Annecy, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with a neoplastic solid tumour with an indication for insertion of a PCVC.

Exclusion criteria

Haematological neoplasm pathology, PCVC removal scheduled within 2 weeks of insertion,
Therapeutic doses of anticoagulants required at inclusion,
PCVC inserted by the femoral vein

Treatment and study plan

Primary outcomes

Thromboembolic complications:

Time frame: one year
Locoregional or disseminated infectious complications:

Time frame: one year

Secondary outcomes

Medical and economic consequences of these complications

Time frame: one year

Sponsors and collaborators

Lead sponsor

Institut de Cancérologie de la Loire

Other

Registry information

Acronym: ONCOCIP

Important dates

Study start: 2010
Primary completion: 2015
Study completion: 2015
First posted: Jan 1, 2014
Registry last updated: Mar 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed